Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-22

Clinical Trial Update: Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating NPC-12Y Gel for skin lesions in Tuberous Sclerosis Complex has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NPC-12Y Gel

Snippet

Sponsor: Nobelpharma | Conditions: Tuberous Sclerosis Complex | Phase 3 | Status: COMPLETED